1. Corporate Officers - E
2. Eisner Mark

Insider Trading History of Eisner Mark

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Eisner Mark since 2023. This trader's CIK number is 1834161. At the time of last reporting, Eisner Mark was the EVP and Chief Medical Officer of Vir Biotechnology, Inc.. (stock ticker symbol VIR). Also see all insider trading activities at Vir Biotechnology, Inc..

Note that in the past Eisner Mark also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Fibrogen Inc (FGEN) by Eisner Mark

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	FGEN	0	$0	31,004	$614,316	0	$0

Yearly summary of insider trading at Vir Biotechnology, Inc. (VIR) by Eisner Mark

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2026	VIR	0	$0	5,594	$49,523	0	$0
2025	VIR	0	$0	31,146	$170,367	0	$0

Insider trading activities at 2 companies by Eisner Mark:

1. Fibrogen Inc (FGEN)

2. Vir Biotechnology, Inc. (VIR)

Table 1. Insider trading of Fibrogen Inc (FGEN) by Eisner Mark

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-06-07	FGEN	Sale	2,042	17.04	34,791
2023-06-02	FGEN	Sale	1,090	18.83	20,524
2023-04-04	FGEN	Sale	9,182	18.78	172,474
2023-03-08	FGEN	Sale	7,363	21.16	155,771
2023-03-10	FGEN	Sale	10,140	20.20	204,797
2023-03-02	FGEN	Sale	1,187	21.87	25,959

Table 2. Insider trading of Vir Biotechnology, Inc. (VIR) by Eisner Mark

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2026-02-24	VIR	Sale	1,616	9.53	15,405
2026-02-25	VIR	Sale	1,889	9.82	18,549
2026-02-23	VIR	Sale	2,089	7.45	15,569
2025-07-15	VIR	Sale	6,796	5.47	37,160
2025-07-17	VIR	Sale	3,586	5.47	19,629
2025-07-15	VIR	Sale	6,796	5.47	37,160
2025-07-17	VIR	Sale	3,586	5.47	19,629
2025-07-15	VIR	Sale	6,796	5.47	37,160
2025-07-17	VIR	Sale	3,586	5.47	19,629

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eisner Mark (EVP and Chief Medical Officer of Vir Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month